Poster

Testing, prevention and PrEP: clinical perspectives and community best practice

P 173
Appropriateness and strategic value of Post-Exposure Prophylaxis (PEP) for HIV today: experience from an Infectious Diseases referral centre, March-December 2023, Italy

P 174
Two years analysis of COBATEST data in Ancona Checkpoint and our experience of “tele visita PrEP”

P 175
“TelePrEP” – A pilot program for the delivery of remote PrEP services

P 176
Testing for HIV in CBVCT services adhering to the COBATEST Network - 2020-2023

P 177
Sexual assault is associated to loss to follow-up for non-occupational Post-Exposure Prophylaxis for HIV

P 178
Evaluating tolerance and safety profiles of Pre-Exposure Prophylaxis (PrEP) for HIV: insights from renal and hepatic function monitoring

P 179
Renal toxicity in a cohort of PrEP users

P 180
Outreach programme in sex-on-premises venues: facilitating linkage to care and prevention services

P 181
Alteration of transaminases in PrEP users: investigation of possible causal factors other than FTC/TDF

P 182
UniversiTest: peer to peer approaching.  Informing and Testing

P 183
Two and a half years of In- and Out-Hospital counselling and testing activities: two different and comprehensive preventive strategies

P 184
HIV drug resistance test harbouring the RT M184V mutation in a PrEP (Pre Exposure Prophylaxis) administered sex worker

P 185
Implementation of a provincial PrEP clinic: analysis by public refundability and new HIV infection diagnoses in Latina

P 186
Differentiated and simplified PrEP delivery in Italy: alignment with WHO guidance is needed

P 187
Evaluation of injectable long acting cabotegravir as response to oral PrEP-related medical issues

P 188
Sexual habits and STDs occurrence in people attending a new PrEP clinic in Brescia

×

Commento audio

Chiudi